EC Number   |
Inhibitors |
Structure |
|---|
   3.6.1.56 | (2Z)-2-methyl-4-[(9H-purin-6-yl)amino]but-2-en-1-ol |
- |
   |
| 3.6.1.56 | 2'-deoxy-8-hydroxyguanosine 5'-triphosphate |
- |
|
| 3.6.1.56 | 2-(dimethylamino)-9-methyl-1,9-dihydro-6H-purin-6-one |
- |
|
| 3.6.1.56 | 2-amino-9-methyl-1,9-dihydro-6H-purin-6-one |
- |
|
| 3.6.1.56 | 2-amino-9-methyl-7,9-dihydro-1H-purine-6,8-dione |
- |
|
| 3.6.1.56 | 2-chloro-6-(1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl)-9H-purine |
- |
|
| 3.6.1.56 | 2-hydroxy-dADP |
competitively inhibits both the 2-hydroxy-dATP hydrolase and 8-hydroxy-dGTP hydrolase activities of hMTH1 |
|
| 3.6.1.56 | 2-hydroxy-dATP |
the hydrolysis of 8-oxo-dGTP (0.01 mM) by wild type and F27A decreases to 42% and 44% of the control in the presence of 0.01 mM 2-hydroxy-dATP. 8-oxo-dGTPase activities of D119A and D119N mutants are not altered in the presence of 2-hydroxy-dATP up to 0.1 mM |
|
| 3.6.1.56 | 2-[2-[(6-methoxy-3-methyl-1H-pyrazolo[3,4-b]quinolin-4-yl)amino]ethoxy]ethanol |
i.e. SCH-51344 |
|
| 3.6.1.56 | 3-[(2-amino-6-methylpyrimidin-4-yl)oxy]propan-1-ol |
- |
|
